Comparto el agradecimiento a SEPAR y al área de neumología ambiental y ocupacional el haberme elegido para el homenaje como miembro de honor en el congreso nacional de este año 2026, junto con otros 14 compañeros
I am pleased to let you know that one more PhD student, Pablo Miguéns Suárez, from our group (E069 – Translational Research in Airway Diseases) has concluded his work.
Maria Belén Alonso Ortiz and Javier de Miguel Díez analyze how COPD with comorbidities represents a major clinical and organizational challenge for the 21st century.
🔍 Read the full article in #OpenRespiratoryArchives
🔗 https://t.co/G6PMZgIrb7
#SEPAR
ERJ Open Research: This national survey highlights notable gender-based disparities in mental health and career advancement among French pulmonologists https://t.co/EoXXfTvpf3
Blood eosinophil count is a key biomarker for guiding corticosteroids and biologic therapies in eosinophilic COPD and asthma, enabling precision treatment that targets those most likely to benefit while reducing unnecessary exposure and adverse effects https://t.co/1UvKX9HuTi
🌍 ¡El rural gallego, a un paso de conquistar Europa!
San Xoán de Río es finalista en los Premios Europeos de Inclusión y Diversidad 2026 🇪🇺.
⏳ ¡QUEDA POCO TIEMPO! 🗳️ Tu voto puede marcar la diferencia.
¡No esperes más y apoya esta candidatura!
🔗 https://t.co/TKeY97zK5E
Lucia Ortega-Ruiz, Claudia Poo-Fernández, Ángel Almansa-López and Maitane Pérez-Urkiza share why they are proud of choosing Pulmonology as their specialty.
🔍 Read the full article in #OpenRespiratoryArchives
🔗https://t.co/lIbkdBkMjt
#SEPAR
@fenaer2 Los pacientes respiratorios pueden tener alguna dificultad para oxigenarse, pero no les impide pensar e identificar a los sabios humanistas. Bien hecho!!!
ERJ: Severe asthma is linked to a significantly higher mortality risk, mainly from respiratory causes, compared to mild-to-moderate asthma. T2 inflammation may contribute to the risk, highlighting the need for early identification and targeted management. https://t.co/VxirOu3j1m
European Respiratory Journal: Fan-to-face therapy is a simple, feasible, low-cost, low-resource nonpharmacological approach to reduce exertional breathlessness during exercise training in adults with chronic lung disease https://t.co/G8S2OLdGiO
After three years of benralizumab, inhaled corticosteroid reduction offers new insight into severe asthma management.
📄 Find these outcomes in #ArchivosdeBronconeumología.
🔗 Access here: https://t.co/5alGMBVacX
#SEPAR
Encantado de poder contribuir a la gestión de este grupo, científicamente brillante, sin olvidad el humanismo reivindicando la galleguidad cordial https://t.co/UyLFt83jSG